V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006342 | 220002453 | 1.62 | 76.5 | Curative (C) | 2018-07-25 | 2018-07-29 | FLAG + Idarubicin | N | N | 220030122 | FLAG + IDARUBICIN |
| 220006343 | 220002453 | null | 91.7 | Disease modification (D) | 2014-10-29 | 2014-10-30 | Nilotinib | N | N | 220030122 | NILOTINIB |
| 220006347 | 220002456 | 1.58 | 64 | Curative (C) | 2017-05-02 | 2017-05-03 | AML 19 TRIAL | Y | N | 220030131 | AML19 TRIAL |
| 220006348 | 220002456 | 1.7 | 53.6 | Curative (C) | 2014-03-06 | 2014-03-06 | FLAG + Idarubicin | Y | null | 220030131 | FLAG + IDARUBICIN |
| 220006349 | 220002456 | null | 76.1 | Disease modification (D) | 2014-03-20 | 2014-03-20 | Nilotinib | N | N | 220030131 | NILOTINIB |
| 220006350 | 220002456 | 1.8 | 90.1 | Curative (C) | 2016-10-12 | 2016-10-12 | AML 19 TRIAL | 01 | N | 220030131 | AML19 TRIAL |
| 220006351 | 220002457 | 1.62 | 103.4 | Curative (C) | null | 2016-06-10 | FLAG + Idarubicin | N | N | 220030141 | FLAG + IDARUBICIN |
| 220006352 | 220002457 | 0 | null | Adjuvant (A) | 2014-12-30 | 2015-04-14 | Nilotinib | null | N | 220030141 | NILOTINIB |
| 220006353 | 220002457 | 1.73 | 70 | Palliative (P) | null | 2013-07-27 | null | null | null | 220030141 | NOT MATCHED |
| 220006354 | 220002457 | 0 | 55.9 | Disease modification (D) | 2015-11-15 | 2015-11-19 | Nilotinib | N | N | 220030141 | NILOTINIB |
| 220006355 | 220002458 | 1.78 | 74.9 | null | 2013-12-19 | 2013-12-20 | AML 19 TRIAL | 1 | N | 220030145 | AML19 TRIAL |
| 220006356 | 220002458 | 1.64 | 88.8 | Curative (C) | null | 2017-08-11 | AML 19 TRIAL | 01 | N | 220030145 | AML19 TRIAL |
| 220006357 | 220016130 | 1.82 | 0 | Radical (R) | 2017-08-05 | 2017-08-05 | Nilotinib | N | N | 220030151 | NILOTINIB |
| 220006358 | 220002459 | 1.67 | null | Curative (C) | 2013-12-23 | 2013-12-23 | FLAG + Idarubicin | 2 | N | 220030154 | FLAG + IDARUBICIN |
| 220006359 | 220011398 | 1.63 | 84.5 | Curative (C) | null | 2017-05-17 | FLAG + Idarubicin | null | N | 220030155 | FLAG + IDARUBICIN |
| 220006360 | 220011398 | 0 | null | Disease modification (D) | 2013-05-27 | 2013-11-29 | Nilotinib | N | N | 220030155 | NILOTINIB |
| 220006361 | 220011398 | 0 | null | Curative (C) | 2015-06-20 | 2015-06-22 | Nilotinib | N | N | 220030155 | NILOTINIB |
| 220006362 | 220011398 | 1.79 | 0 | Curative (C) | 2014-09-06 | 2014-09-07 | Nilotinib | N | N | 220030155 | NILOTINIB |
| 220006363 | 220011398 | 1.63 | 80.3 | Curative (C) | 2016-04-12 | 2016-04-13 | AML 19 TRIAL | N | N | 220030155 | AML19 TRIAL |
| 220006364 | 220002460 | 0 | 0 | Palliative (P) | 2014-08-14 | 2014-08-14 | Nilotinib | N | N | 220030166 | NILOTINIB |
| 220006365 | 220002461 | 1.7 | 63.4 | Adjuvant (A) | 2018-10-17 | 2018-10-18 | FLAG + Idarubicin | 2 | N | 220030168 | FLAG + IDARUBICIN |
| 220006366 | 220002461 | 1.84 | 76 | Curative (C) | 2014-04-04 | 2014-04-05 | AML 19 TRIAL | Y | N | 220030168 | AML19 TRIAL |
| 220006367 | 220002461 | null | null | Curative (C) | 2015-06-03 | 2015-06-03 | null | Y | N | 220030168 | NOT MATCHED |
| 220006368 | 220002461 | 1.75 | null | Curative (C) | 2014-10-27 | 2014-10-27 | FLAG + Idarubicin | Y | N | 220030168 | FLAG + IDARUBICIN |
| 220006369 | 220002462 | 1.8 | 52.51 | Curative (C) | 2017-10-30 | 2017-11-04 | AML 19 TRIAL | Y | N | 220030181 | AML19 TRIAL |
| 220006370 | 220002463 | 1.75 | null | Curative (C) | 2016-07-08 | 2016-07-08 | AML 19 TRIAL | N | N | 220030182 | AML19 TRIAL |
| 220006371 | 220011400 | 1.61 | 69.4 | Curative (C) | 2014-08-07 | 2014-08-07 | Nilotinib | 2 | N | 220030183 | NILOTINIB |
| 220006372 | 220002464 | null | 35.3 | Curative (C) | 2014-03-01 | 2014-03-01 | APML Consolidation III ATRA, Idarubicin, Cytarabine | 2 | N | 220030184 | NOT MATCHED |
| 220006373 | 220002464 | 1.96 | 52.6 | Curative (C) | 2017-09-29 | 2017-09-29 | AML 19 TRIAL | Y | N | 220030184 | AML19 TRIAL |
| 220006374 | 220002465 | 1.9 | 0 | null | 2012-11-02 | 2015-11-16 | Nilotinib | N | N | 220030187 | NILOTINIB |
| 220006375 | 220002466 | 1.66 | 75.8 | Curative (C) | null | 2017-04-20 | AML 19 TRIAL | 1 | N | 220030188 | AML19 TRIAL |
| 220006376 | 220002466 | 164 | 94 | Not known (9) | 2013-06-14 | 2013-06-16 | Nilotinib | 02 | N | 220030188 | NILOTINIB |
| 220006377 | 220002466 | null | 0 | Curative (C) | null | 2014-12-06 | Nilotinib | 02 | N | 220030188 | NILOTINIB |
| 220006378 | 220002467 | 0 | null | Disease modification (D) | null | 2017-02-01 | Nilotinib | N | N | 220030191 | NILOTINIB |
| 220006379 | 220002468 | null | 73.15 | Curative (C) | 2017-11-14 | 2017-11-14 | null | null | null | 220030193 | NOT MATCHED |
| 220006380 | 220002468 | 1.79 | 56.9 | Curative (C) | 2014-11-17 | 2014-11-23 | FLAG + Idarubicin | N | N | 220030193 | FLAG + IDARUBICIN |
| 220006381 | 220002468 | 0 | 0 | Palliative (P) | 2016-09-17 | 2016-09-21 | Nilotinib | N | N | 220030193 | NILOTINIB |
| 220006382 | 220002468 | null | 0 | Curative (C) | 2016-04-09 | 2016-04-20 | AML MyeChild 01 IT Cyt | N | N | 220030193 | NOT MATCHED |
| 220006383 | 220002468 | 0 | 0 | Curative (C) | 2017-12-05 | 2017-12-06 | Nilotinib | N | N | 220030193 | NILOTINIB |
| 220006384 | 220021246 | 0 | null | Curative (C) | 2017-08-22 | 2017-08-22 | null | N | N | 220030200 | NOT MATCHED |
| 220006387 | 220022160 | 1.58 | null | Curative (C) | 2016-08-12 | 2016-08-14 | FLAG + Idarubicin | N | N | 220030207 | FLAG + IDARUBICIN |
| 220006388 | 220002469 | 1.72 | 76.8 | Curative (C) | 2017-12-22 | 2017-12-23 | FLAG + Idarubicin | N | N | 220030208 | FLAG + IDARUBICIN |
| 220006389 | 220002469 | 0 | 15.3 | Curative (C) | 2013-04-09 | 2013-04-09 | AML Interim Guidelines | N | null | 220030208 | NOT MATCHED |
| 220006390 | 220002469 | 0 | 83.5 | Curative (C) | 2013-04-14 | 2013-04-15 | Nilotinib | 02 | N | 220030208 | NILOTINIB |
| 220006391 | 220002469 | 0 | 0 | Adjuvant (A) | 2013-10-12 | 2013-10-13 | Nilotinib | 02 | Y | 220030208 | NILOTINIB |
| 220006392 | 220002470 | null | 0 | Disease modification (D) | 2013-08-03 | 2013-08-03 | Nilotinib | N | N | 220030216 | NILOTINIB |
| 220006393 | 220011405 | 1.82 | 75.1 | null | 2015-04-07 | 2015-04-07 | FLAG + Idarubicin | 01 | N | 220030217 | FLAG + IDARUBICIN |
| 220006394 | 220002471 | 1.75 | 101.4 | null | null | 2015-11-03 | FLAG + Idarubicin | N | null | 220030218 | FLAG + IDARUBICIN |
| 220006395 | 220002471 | null | 69.5 | Unknown (U) | 2017-03-17 | 2017-03-17 | FLAG + Idarubicin | 2 | N | 220030218 | FLAG + IDARUBICIN |
| 220006396 | 220002471 | null | 101.6 | Curative (C) | 2013-12-13 | 2013-12-13 | AML Interim Guidelines FLA -Ida | 02 | N | 220030218 | NOT MATCHED |